New insights into the roles of ATM and DNA-PKcs in the cellular response to oxidative stress

Cancer Letters

Volumn 327, Issue 1-2, 2012, Pages 103-110

  Chen, Benjamin P C ^a   Li, Mengxia ^a,b   Asaithamby, Aroumougame ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ATM; ATR; DNA PKcs; Hypoxia; OCDL; Oxidative stress

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNA DEPENDENT PROTEIN KINASE; DNA DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELLULAR STRESS RESPONSE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; ENERGY METABOLISM; ENZYME ACTIVATION; GENE CONTROL; HUMAN; HYPOXIA; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE PROTEINS; DNA REPLICATION; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NF-KAPPA B; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 84867478618     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.12.004     Document Type: Article

References (96)

1. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3:155-168.
2. Lovejoy C.A., Cortez D. Common mechanisms of PIKK regulation. DNA Repair (Amsterdam) 2009, 8:1004-1008.
3. Bartek J., Lukas C., Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 2004, 5:792-804.
4. Cimprich K.A., Cortez D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 2008, 9:616-627.
5. Weterings E., Chen D.J. The endless tale of non-homologous end-joining. Cell Res. 2008, 18:114-124.
6. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
7. Mu J.J., Wang Y., Luo H., Leng M., Zhang J., Yang T., Besusso D., Jung S.Y., Qin J. A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J. Biol. Chem. 2007, 282:17330-17334.
8. Callen E., Jankovic M., Wong N., Zha S., Chen H.T., Difilippantonio S., Di Virgilio M., Heidkamp G., Alt F.W., Nussenzweig A., Nussenzweig M. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol. Cell 2009, 34:285-297.
9. Tomimatsu N., Mukherjee B., Burma S. Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells. EMBO Rep. 2009, 10:629-635.
10. Kryston T.B., Georgiev A.B., Pissis P., Georgakilas A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711:193-201.
11. Shlomai J. Redox control of protein-DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication. Antioxid. Redox Signaling 2010, 13:1429-1476.
12. Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000, 29:222-230.
13. Zangar R.C., Davydov D.R., Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 2004, 199:316-331.
14. Kohchi C., Inagawa H., Nishizawa T., Soma G. ROS and innate immunity. Anticancer Res. 2009, 29:817-821.
15. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
16. Lavin M.F., Gueven N., Bottle S., Gatti R.A. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br. Med. Bull. 2007, 81-82:129-147.
17. Rotman G., Shiloh Y. The ATM gene and prote. Cancer Surv. 1997, 29:285-304.
18. Rotman G., Shiloh Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?. BioEssays 1997, 19:911-917.
19. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 1999, 96:9915-9919.
20. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 2001, 61:1849-1854.
21. Stern N., Hochman A., Zemach N., Weizman N., Hammel I., Shiloh Y., Rotman G., Barzilai A. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J. Biol. Chem. 2002, 277:602-608.
22. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
23. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA 1996, 93:13084-13089.
24. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 1996, 10:2411-2422.
25. Reliene R., Schiestl R.H. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair (Amsterdam) 2006, 5:852-859.
26. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
27. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304:93-96.
28. Lee J.H., Paull T.T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005, 308:551-554.
29. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
30. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
31. Chou W.C., Wang H.C., Wong F.H., Ding S.L., Wu P.E., Shieh S.Y., Shen C.Y. Chk2-dependent phosphorylation of XRCC1 in the DNA damage response promotes base excision repair. EMBO J. 2008, 27:3140-3150.
32. Das B.B., Antony S., Gupta S., Dexheimer T.S., Redon C.E., Garfield S., Shiloh Y., Pommier Y. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J. 2009, 28:3667-3680.
33. Ben Hassine S., Arcangioli B. Tdp1 protects against oxidative DNA damage in non-dividing fission yeast. EMBO J. 2009, 28:632-640.
34. Wiederhold L., Leppard J.B., Kedar P., Karimi-Busheri F., Rasouli-Nia A., Weinfeld M., Tomkinson A.E., Izumi T., Prasad R., Wilson S.H., Mitra S., Hazra T.K. AP endonuclease-independent DNA base excision repair in human cells. Mol. Cell 2004, 15:209-220.
35. Lebedeva N.A., Rechkunova N.I., Lavrik O.I. AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1. FEBS Lett. 2011, 585:683-686.
36. Gollapalle E., Wang R., Adetolu R., Tsao D., Francisco D., Sigounas G., Georgakilas A.G. Detection of oxidative clustered DNA lesions in X-irradiated mouse skin tissues and human MCF-7 breast cancer cells. Radiat. Res. 2007, 167:207-216.
37. Peddi P., Francisco D.C., Cecil A.M., Hair J.M., Panayiotidis M.I., Georgakilas A.G. Processing of clustered DNA damage in human breast cancer cells MCF-7 with partial DNA-PKcs deficiency. Cancer Lett. 2008, 269:174-183.
38. Peddi P., Loftin C.W., Dickey J.S., Hair J.M., Burns K.J., Aziz K., Francisco D.C., Panayiotidis M.I., Sedelnikova O.A., Bonner W.M., Winters T.A., Georgakilas A.G. DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells. Free Radic. Biol. Med. 2010, 48:1435-1443.
39. Georgakilas A.G. A possible role of repair proteins BRCA1 and in the processing of oxidative DNA damage. J. Biochem. Tech. 2008, 1:9-10.
40. Parlanti E., Locatelli G., Maga G., Dogliotti E. Human base excision repair complex is physically associated to DNA replication and cell cycle regulatory proteins. Nucleic Acids Res. 2007, 35:1569-1577.
41. Levy N., Martz A., Bresson A., Spenlehauer C., de Murcia G., Menissier-de Murcia J. XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage. Nucleic Acids Res. 2006, 34:32-41.
42. Toulany M., Dittmann K., Fehrenbacher B., Schaller M., Baumann M., Rodemann H.P. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. DNA Repair (Amsterdam) 2008, 7:1746-1756.
43. Zhang X., Zhu Y., Geng L., Wang H., Legerski R.J. Artemis is a negative regulator of p53 in response to oxidative stress. Oncogene 2009, 28:2196-2204.
44. Riballo E., Kuhne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell 2004, 16:715-724.
45. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 1996, 382:551-555.
46. Zhu C., Bogue M.A., Lim D.S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996, 86:379-389.
47. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., van der Stoep N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity 1997, 7:653-665.
48. Ouyang H., Nussenzweig A., Kurimasa A., Soares V.C., Li X., Cordon-Cardo C., Li W., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J. Exp. Med. 1997, 186:921-929.
49. Narasimhaiah R., Tuchman A., Lin S.L., Naegele J.R. Oxidative damage and defective DNA repair is linked to apoptosis of migrating neurons and progenitors during cerebral cortex development in Ku70-deficient mice. Cereb. Cortex 2005, 15:696-707.
50. Reliene R., Goad M.E., Schiestl R.H. Developmental cell death in the liver and newborn lethality of Ku86 deficient mice suppressed by antioxidant N-acetyl-cysteine. DNA Repair (Amst) 2006, 5:1392-1397.
51. Roberts S.A., Strande N., Burkhalter M.D., Strom C., Havener J.M., Hasty P., Ramsden D.A. Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends. Nature 2010, 464:1214-1217.
52. Semenza G.L. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr. Pharm. Des. 2009, 15:3839-3843.
53. Liu Y.V., Baek J.H., Zhang H., Diez R., Cole R.N., Semenza G.L. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol. Cell 2007, 25:207-217.
54. Zhou J., Schmid T., Frank R., Brune B. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J. Biol. Chem. 2004, 279:13506-13513.
55. Bencokova Z., Kaufmann M.R., Pires I.M., Lecane P.S., Giaccia A.J., Hammond E.M. ATM activation and signaling under hypoxic conditions. Mol. Cell. Biol. 2009, 29:526-537.
56. Cam H., Easton J.B., High A., Houghton P.J. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha. Mol. Cell 2010, 40:509-520.
57. Ousset M., Bouquet F., Fallone F., Biard D., Dray C., Valet P., Salles B., Muller C. Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: role in the physiopathology of the disease. Cell Cycle 2010, 9:2814-2822.
58. Hansen P.A., Wang W., Marshall B.A., Holloszy J.O., Mueckler M. Dissociation of GLUT4 translocation and insulin-stimulated glucose transport in transgenic mice overexpressing GLUT1 in skeletal muscle. J. Biol. Chem. 1998, 273:18173-18179.
59. Armata H.L., Golebiowski D., Jung D.Y., Ko H.J., Kim J.K., Sluss H.K. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol. Cell. Biol. 2010, 30:5787-5794.
60. Karvinen H., Pasanen E., Rissanen T.T., Korpisalo P., Vahakangas E., Jazwa A., Giacca M., Yla-Herttuala S. Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle. Gene Ther. 2011.
61. Kang M.J., Jung S.M., Kim M.J., Bae J.H., Kim H.B., Kim J.Y., Park S.J., Song H.S., Kim D.W., Kang C.D., Kim S.H. DNA-dependent protein kinase is involved in heat shock protein-mediated accumulation of hypoxia-inducible factor-1alpha in hypoxic preconditioned HepG2 cells. FEBS J. 2008, 275:5969-5981.
62. Bouquet F., Ousset M., Biard D., Fallone F., Dauvillier S., Frit P., Salles B., Muller C. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. J. Cell Sci. 2011, 124:1943-1951.
63. Um J.H., Kang C.D., Bae J.H., Shin G.G., Kim D.W., Chung B.S., Kim S.H. Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells. Exp. Mol. Med. 2004, 36:233-242.
64. Wirthner R., Wrann S., Balamurugan K., Wenger R.H., Stiehl D.P. Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts. Carcinogenesis 2008, 29:2306-2316.
65. Bozulic L., Surucu B., Hynx D., Hemmings B.A. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol. Cell 2008, 30:203-213.
66. Surucu B., Bozulic L., Hynx D., Parcellier A., Hemmings B.A. In vivo analysis of protein kinase B (PKB)/Akt regulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response and tumorigenesis. J. Biol. Chem. 2008, 283:30025-30033.
67. Alexander A., Cai S.L., Kim J., Nanez A., Sahin M., MacLean K.H., Inoki K., Guan K.L., Shen J., Person M.D., Kusewitt D., Mills G.B., Kastan M.B., Walker C.L. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. USA 2010, 107:4153-4158.
68. Kim S.G., Choo A.Y., Blenis J. ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulation. Mol. Cell 2010, 40:501-502.
69. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., Witters L.A., Ellisen L.W., Kaelin W.G. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004, 18:2893-2904.
70. Shaw R.J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxford) 2009, 196:65-80.
71. Alexander A., Walker C.L. The role of LKB1 and AMPK in cellular responses to stress and damage. FEBS Lett. 2011, 585:952-957.
72. Griguer C.E., Oliva C.R., Kelley E.E., Giles G.I., Lancaster J.R., Gillespie G.Y. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res. 2006, 66:2257-2263.
73. Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signaling 2005, 7:395-403.
74. Morgan M.J., Liu Z.G. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011, 21:103-115.
75. Miyamoto S. Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res. 2011, 21:116-130.
76. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 1995, 268:1619-1621.
77. Wu Z.H., Shi Y., Tibbetts R.S., Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006, 311:1141-1146.
78. Wu Z.H., Wong E.T., Shi Y., Niu J., Chen Z., Miyamoto S., Tergaonkar V. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol. Cell 2010, 40:75-86.
79. Ahmed K.M., Li J.J. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic. Biol. Med. 2008, 44:1-13.
80. Grosjean-Raillard J., Tailler M., Ades L., Perfettini J.L., Fabre C., Braun T., De Botton S., Fenaux P., Kroemer G. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 2009, 28:1099-1109.
81. Rosato R.R., Kolla S.S., Hock S.K., Almenara J.A., Patel A., Amin S., Atadja P., Fisher P.B., Dent P., Grant S. Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathway. J. Biol. Chem. 2010, 285:10064-10077.
82. Panta G.R., Kaur S., Cavin L.G., Cortes M.L., Mercurio F., Lothstein L., Sweatman T.W., Israel M., Arsura M. ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage. Mol. Cell. Biol. 2004, 24:1823-1835.
83. Rajagopalan S., Moyle M.W., Joosten I., Long E.O. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci. Signal 2010, 3:14.
84. Ju J., Naura A.S., Errami Y., Zerfaoui M., Kim H., Kim J.G., Abd Elmageed Z.Y., Abdel-Mageed A.B., Giardina C., Beg A.A., Smulson M.E., Boulares A.H. Phosphorylation of p50 NF-kappaB at a single serine residue by DNA-dependent protein kinase is critical for VCAM-1 expression upon TNF treatment. J. Biol. Chem. 2010, 285:41152-41160.
85. Liu L., Kwak Y.T., Bex F., Garcia-Martinez L.F., Li X.H., Meek K., Lane W.S., Gaynor R.B. DNA-dependent protein kinase phosphorylation of IkappaB alpha and IkappaB beta regulates NF-kappaB DNA binding properties. Mol. Cell. Biol. 1998, 18:4221-4234.
86. Hammond E.M., Denko N.C., Dorie M.J., Abraham R.T., Giaccia A.J. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 2002, 22:1834-1843.
87. Hammond E.M., Dorie M.J., Giaccia A.J. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 2003, 278:12207-12213.
88. Hammond E.M., Dorie M.J., Giaccia A.J. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res. 2004, 64:6556-6562.
89. Hammond E.M., Giaccia A.J. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair (Amsterdam) 2004, 3:1117-1122.
90. Hammond E.M., Green S.L., Giaccia A.J. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat. Res. 2003, 532:205-213.
91. Szekeres T., Fritzer-Szekeres M., Elford H.L. The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy. Crit. Rev. Clin. Lab. Sci. 1997, 34:503-528.
92. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300:1542-1548.
93. Loffler M., Schimpff-Weiland G., Follmann H. Deoxycytidylate shortage is a cause of G1 arrest of ascites tumor cells under oxygen deficiency. FEBS Lett. 1983, 156:72-76.
94. Shoelson S.E. Banking on ATM as a new target in metabolic syndrome. Cell Metab. 2006, 4:337-338.
95. Wong R.H., Chang I., Hudak C.S., Hyun S., Kwan H.Y., Sul H.S. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 2009, 136:1056-1072.
96. Brown J.M. Tumor hypoxia in cancer therapy. Methods Enzymol. 2007, 435:297-321.